Literature DB >> 8436914

Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes.

D L Morris1, T L Rothstein.   

Abstract

Populations of murine peritoneal B-1 and splenic B-2 cells, highly purified by negative selection techniques, were used to demonstrate that B-1 cells completely fail to enter cell cycle in response to surface immunoglobulin M (sIgM) crosslinking without any decrease in cell number or viability. This failure of B-1 cell responsiveness appears to represent a specific defect in sIgM-derived signaling inasmuch as stimulation to enter S phase occurs normally in response to activated and fixed T cells, and to lipopolysaccharide (LPS). The level at which sIgM signaling fails was determined by evaluating the nuclear expression of the transcription factor complex, NF-kappa B, whose sIgM-mediated induction in B-2 cells is dependent on protein kinase C (PKC) activation but is independent of protein synthesis. There was no induction of nuclear NF-kappa B in B-1 cells stimulated by sIgM crosslinking, although NF-kappa B was stimulated by phorbol myristate acetate and by LPS. In contrast, NF-kappa B was induced in B-2 cells by all three stimuli. Thus, in B-1 cells, the sIgM-mediated induction of a transcription factor that is substantially stimulated by anti-IgM in B-2 cells is blocked. However, all sIgM-derived signaling in B-1 cells was not impaired inasmuch as anti-IgM increased I-A antigen expression. These results strongly suggest that sIgM receptor-mediated signaling in B-1 cells is interrupted early in the signal transduction pathway, at a point proximal to the activation of PKC. These results further demonstrate that transcription factor induction can be used to analyze the level at which receptor-mediated signaling is blocked.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436914      PMCID: PMC2190944          DOI: 10.1084/jem.177.3.857

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.

Authors:  R J Noelle; M Roy; D M Shepherd; I Stamenkovic; J A Ledbetter; A Aruffo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

2.  Elevated levels of protein kinase C activity and alpha-isoenzyme expression in murine peritoneal B cells.

Authors:  D P Cohen; T L Rothstein
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

3.  Polyreactive low-affinity IgM antibodies produced by CD5+ B cells.

Authors:  T L Rothstein
Journal:  Immunol Today       Date:  1990-05

4.  Inducible nuclear expression of NF-kappa B in primary B cells stimulated through the surface Ig receptor.

Authors:  J L Liu; T C Chiles; R J Sen; T L Rothstein
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

5.  Elevated expression of Pgp-1 (Ly-24) by murine peritoneal B lymphocytes.

Authors:  T P Murphy; D L Kolber; T L Rothstein
Journal:  Eur J Immunol       Date:  1990-05       Impact factor: 5.532

Review 6.  The CD5 B cell.

Authors:  T J Kipps
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

7.  Peritoneal B cells respond to phorbol esters in the absence of co-mitogen.

Authors:  T L Rothstein; D L Kolber
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

8.  Phorbol ester responsiveness of murine Ly-1-lineage B cells from normal and viable motheaten mutant mice.

Authors:  D L Kolber; L D Shultz; T L Rothstein
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

9.  Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways.

Authors:  Y Z Cong; E Rabin; H H Wortis
Journal:  Int Immunol       Date:  1991-05       Impact factor: 4.823

10.  Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.

Authors:  S Ghosh; D Baltimore
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

View more
  38 in total

1.  A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.

Authors:  Hiroaki Kaku; Kai Fan Cheng; Yousef Al-Abed; Thomas L Rothstein
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

Review 2.  Natural IgM in immune equilibrium and harnessing their therapeutic potential.

Authors:  Srini V Kaveri; Gregg J Silverman; Jagadeesh Bayry
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

3.  Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection.

Authors:  Vishal Sindhava; Michael E Woodman; Brian Stevenson; Subbarao Bondada
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

Review 4.  L2pB1: a new player in autoimmunity.

Authors:  Xuemei Zhong; Thomas L Rothstein
Journal:  Mol Immunol       Date:  2010-12-31       Impact factor: 4.407

Review 5.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

6.  Regulation of B-1 cell activation and its autoantibody production by Lyn kinase-regulated signallings.

Authors:  H Ochi; H Takeshita; T Suda; S Nisitani; T Honjo; T Watanabe
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

7.  FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling.

Authors:  Zilu Zhu; Ran Li; Hao Li; Tong Zhou; Randall S Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

8.  Developmental expression of B cell molecules in equine lymphoid tissues.

Authors:  J M B Prieto; R L Tallmadge; M J B Felippe
Journal:  Vet Immunol Immunopathol       Date:  2016-12-13       Impact factor: 2.046

9.  Murine B1 B cells require IL-5 for optimal T cell-dependent activation.

Authors:  L D Erickson; T M Foy; T J Waldschmidt
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

10.  Attenuated liver fibrosis in the absence of B cells.

Authors:  Tatiana I Novobrantseva; Gerard R Majeau; Aldo Amatucci; Sophia Kogan; Ian Brenner; Stefano Casola; Mark J Shlomchik; Victor Koteliansky; Paula S Hochman; Alexander Ibraghimov
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.